Nurosym Launches Wearable VNS Device Amid Surging Interest in Neuromodulation Market
Neuromodulation company Nurosym has introduced a new wearable vagus nerve stimulation (VNS) device, entering a market that is experiencing significant growth in both consumer and clinical interest. This launch coincides with a broader trend in the neuromodulation sector, where wearable technology is converging with evidence-based neurological treatments. Traditionally, VNS therapy involved surgically implanted devices, but Nurosym's non-invasive wearable platform allows for transcutaneous stimulation, typically applied at the ear or neck, without the risks and costs associated with surgery. This innovation positions the device for wider adoption across various therapeutic areas, including anxiety, depression, inflammation, and autonomic dysfunction.
